Skip to main content
. 2018 Sep 4;2018(9):CD013102. doi: 10.1002/14651858.CD013102

Bruhn 2013.

Methods Randomised trial
Participants 193 participants with chronic pain (intervention (1) 70: intervention (2) 63: control 60)
6 general practices
United Kingdom
Year of study: March 201 to not stated.
Interventions The intervention was pharmacist medication review with and without prescribing.
Control patients received usual care. Patients attended a face‐to‐face consultation with the pharmacist at which a pharmaceutical care plan was agreed. The plan included medical history, current conditions; known allergies and adverse drug reactions; relevant laboratory results; pain‐related medications prescribed in the previous 10 years; current pain‐related prescription medications; current symptoms; lifestyle issues, including units of alcohol consumed each week; recommendations for changes to medication (if any); whether non‐pharmaceutical treatments had been considered; and any other relevant issues. In the prescribing arm, prescriptions for medicines were issued by the pharmacist. Patients were followed up either by phone or face‐to‐face, at each pharmacist’s discretion.
Outcomes Chronic Pain Grade intensity
Notes Funding source: Medical Research Council (grant ID: 85356).
Conflict of interest: None reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk All participating pharmacists took part in a 2‐day course updating them about pain management. As part of the training, participants defined and agreed the treatment algorithm they would all use.
Allocation concealment (selection bias) Low risk Patients returning completed questionnaires were randomised by the researcher using a telephone randomisation service with a random number allocation which ensured allocation concealment.
Blinding of participants and personnel (performance bias) 
 All Outcomes/Outcome 1 Low risk Personnel were necessarily unblinded, but this is unlikely to bias the results.
Blinding of outcome assessment (detection bias) 
 All Outcomes/Outcome 1 High risk Largely self‐report and, as patients are unblinded, susceptible to bias
Incomplete outcome data (attrition bias) 
 All outcomes High risk Between group attrition >10%.
Selective reporting (reporting bias) Low risk All main results reported
Other bias Low risk None